FAILSAFE – Fungal AMR Innovations for LMICS: Solutions and Access For Everyone

Welcome

FAILSAFE is part of a global effort to curb fungal AMR through interdisciplinary research and the development of sustainable, long-term partnerships. By supporting innovative research, FAILSAFE hopes to drive tangible improvements in the prevention, diagnosis, and treatment of fungal diseases globally.

Join the FAILSAFE Medical Mycology Network

About us

The FAILSAFE project, led by the University of Exeter’s MRC Centre for Medical Mycology (MRCrnCMM) and funded by the UK Department of Health’s Global AMR Innovation Fund, addresses the growing threat of antifungal resistance (AFR).

Find out more

Awarded Research

In its first funding wave, FAILSAFE supported 78 researchers across 13 countries to accelerate solutions for this global issue, which heavily impacts low- and middle-income countries (LMICs).

Find out more

Members

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit.

Find out more

Products and Solutions

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Find out more

FUNDING

NETWORK

AWARDED RESEARCH

SPOTLIGHT ON AFR

1 billion people

suffer from fungal infections each year lorem lorem lorem lorem

1.5 million deaths

occur annually due to fungal infections

Only 4 classes

of antifungal drugs

11 pathogens

exhibiting resistance to one or more antifungal agents

£3.5 million

available FAILSAFE funding for research and development to combat fungal AMR worldwide

£1.7 million awarded

in 2024 to support groundbreaking fungal AMR research

Meet the team